Investigation of Anti-obesity Properties of Lactobacillus Sakei in Obese Human Subjects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

114 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-10

Study Completion Date

2018-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, we are going to investigate the efficacy of Lactobacillus Sakei on reduction of fat mass assessed by DEXA compared to plaebo.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Lactobacillus Delbrueckii Subsp. Bulgaricus on Human's Weight Reduction

NCT06244186

Overweight and Obesity

COMPLETED NA

The Effect of Supplementation With Species of Lactobacillus on Anthropometric Measurements

NCT02448940

Overweight and Obesity

COMPLETED NA

The Effect of Intervention With Probiotic K56 on Body Fat Reduction in Obese Subjects

NCT05192811

Obesity

UNKNOWN NA

Effect of a Probiotic, Lactobacillus Gasseri BNR17, on Body Composition and Weight Management in Overweight Adults

NCT04260997

Weight Management

COMPLETED NA

Effects of TRE With Lactobacillus Plantarum LP-KFY04 Supplementation on Overweight / Obese Individuals

NCT06423287

Obesity

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We are going to enroll subjects whose BMI is equal to higher than 25, and randomly assigned study material or placebo at 1:1 ratio. The treatment duration is 12 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Double blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lactobacillus sakei

2 packs per day

Group Type EXPERIMENTAL

Lactobacillus sakei

Intervention Type DIETARY_SUPPLEMENT

1 pack contained 5 x 109 cfu

Control

2 packs per day

Group Type PLACEBO_COMPARATOR

Lactobacillus sakei

Intervention Type DIETARY_SUPPLEMENT

1 pack contained 5 x 109 cfu

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lactobacillus sakei

1 pack contained 5 x 109 cfu

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 20-65 years
* BMI equal to higher than 25 kg/m2

Exclusion Criteria

* under anti-obesity medication
* uncontrolled diabetes
* uncontrolled hypertension
* any medications can influence to body weight such as thiazolidinedione, GLP-1 analogue, SGLT2 inhibitor, diuretics
* thyroid function test abnormality
* malignancy within 5 years
* immune compromised hosts or under immune suppressants
* antibiotics or probiotics withing 2 weeks
* any intervention to reduce body weight within 6 months

Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes